+

SV2002000601A - Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados - Google Patents

Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Info

Publication number
SV2002000601A
SV2002000601A SV2001000601A SV2001000601A SV2002000601A SV 2002000601 A SV2002000601 A SV 2002000601A SV 2001000601 A SV2001000601 A SV 2001000601A SV 2001000601 A SV2001000601 A SV 2001000601A SV 2002000601 A SV2002000601 A SV 2002000601A
Authority
SV
El Salvador
Prior art keywords
aril
derivatives
manufacture
antranilic
acids
Prior art date
Application number
SV2001000601A
Other languages
English (en)
Inventor
Chen Michael Huai Gu
Davis Edward Mark
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2002000601A publication Critical patent/SV2002000601A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PRESENTE INVENCION SE RELACIONA CON UN PROCESO PARA LA PREPARACION DE ACIDOS N-ACRILANTRANILICOS, Y CON UN PROCESO PARA LA PREPARACION DE ESTERES N-ARIL ANTRANILICOS, AMIDAS Y ESTERES HIDROXAMICOS.
SV2001000601A 2000-08-25 2001-08-15 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados SV2002000601A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25

Publications (1)

Publication Number Publication Date
SV2002000601A true SV2002000601A (es) 2002-04-03

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000601A SV2002000601A (es) 2000-08-25 2001-08-15 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Country Status (31)

Country Link
EP (1) EP1313694A1 (es)
JP (1) JP2004507518A (es)
KR (1) KR20030059115A (es)
CN (1) CN1458921A (es)
AP (1) AP2001002249A0 (es)
AR (1) AR032175A1 (es)
AU (1) AU2001277044A1 (es)
BG (1) BG107635A (es)
BR (1) BR0113520A (es)
CA (1) CA2420003A1 (es)
CZ (1) CZ2003477A3 (es)
DO (1) DOP2001000238A (es)
EA (1) EA200300187A1 (es)
GT (1) GT200100174A (es)
HN (1) HN2001000216A (es)
HU (1) HUP0300828A2 (es)
IL (1) IL154507A0 (es)
IS (1) IS6724A (es)
MA (1) MA26949A1 (es)
MX (1) MXPA03001654A (es)
NO (1) NO20030844L (es)
PA (1) PA8526501A1 (es)
PE (1) PE20020393A1 (es)
PL (1) PL360699A1 (es)
SK (1) SK2072003A3 (es)
SV (1) SV2002000601A (es)
TN (1) TNSN01127A1 (es)
UY (1) UY26908A1 (es)
WO (1) WO2002018319A1 (es)
YU (1) YU14303A (es)
ZA (1) ZA200301182B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
PT2130537E (pt) 2002-03-13 2012-12-20 Array Biopharma Inc Derivados de benzimidazole n3 alquilado como inibidores de mek
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
CA2542210A1 (en) 2003-10-21 2005-05-06 Warner-Lambert Company Llc Polymorphic form of n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
PL1689233T3 (pl) 2003-11-19 2012-11-30 Array Biopharma Inc Bicykliczne inhibitory MEK
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
CN102786482A (zh) 2003-11-21 2012-11-21 阿雷生物药品公司 Akt蛋白激酶抑制剂
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
DK2332909T3 (da) 2005-04-13 2014-11-10 Astex Therapeutics Ltd Hydroxybenzamidderivater og deres anvendelse som inhibitorer af hsp90
ES2405785T3 (es) 2005-05-18 2013-06-03 Array Biopharma Inc. Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101631778B (zh) 2006-07-06 2013-05-08 阵列生物制药公司 作为akt蛋白激酶抑制剂的环戊二烯并[d]嘧啶
US9303040B2 (en) 2006-07-06 2016-04-05 Array Biopharma Inc. Substituted piperazines as AKT inhibitors
DE602007011628D1 (de) 2006-07-06 2011-02-10 Array Biopharma Inc Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
KR101650956B1 (ko) 2007-07-05 2016-08-24 어레이 바이오파마 인크. Ａｋｔ 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
KR101624361B1 (ko) 2007-07-05 2016-05-25 어레이 바이오파마 인크. Ａｋｔ 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
AU2009204019B2 (en) 2008-01-09 2014-02-20 Array Biopharma Inc. Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
ES2422733T3 (es) 2008-01-09 2013-09-13 Array Biopharma Inc Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
US20120316337A1 (en) * 2010-02-19 2012-12-13 Universite Du Maine Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group
CA2789373A1 (en) * 2010-02-19 2011-08-25 Centre National De La Recherche Scientifique Process for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group
CA2844699C (en) 2011-04-01 2019-05-07 Genentech, Inc. Combinations of akt inhibitor compounds and abiraterone, and methods of use
CN103841976A (zh) 2011-04-01 2014-06-04 基因泰克公司 Akt和mek抑制剂化合物的组合及其使用方法
WO2014059422A1 (en) * 2012-10-12 2014-04-17 Exelixis, Inc. Novel process for making compounds for use in the treatment of cancer
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
WO1998037881A1 (en) * 1997-02-28 1998-09-03 Warner Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
ES2274572T3 (es) * 1997-07-01 2007-05-16 Warner-Lambert Company Llc Derivados de acido 2-(4-bromo- o 4-yodo-fenilamino) benzoico y su uso como inhibidor de mek.
CA2290506C (en) * 1997-07-01 2005-12-27 Warner-Lambert Company 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
EP1171418B1 (en) * 1999-04-21 2004-12-29 Warner-Lambert Company LLC Method for making 2-(n-phenylamino)benzoic acids

Also Published As

Publication number Publication date
PA8526501A1 (es) 2002-07-30
IS6724A (is) 2003-02-20
KR20030059115A (ko) 2003-07-07
YU14303A (sh) 2006-08-17
IL154507A0 (en) 2003-09-17
PE20020393A1 (es) 2002-05-09
EP1313694A1 (en) 2003-05-28
BG107635A (bg) 2004-09-30
NO20030844D0 (no) 2003-02-24
UY26908A1 (es) 2001-11-30
GT200100174A (es) 2002-07-18
CA2420003A1 (en) 2002-03-07
MA26949A1 (fr) 2004-12-20
AP2001002249A0 (en) 2001-09-30
ZA200301182B (en) 2004-05-12
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (cs) 2003-10-15
PL360699A1 (en) 2004-09-20
AR032175A1 (es) 2003-10-29
TNSN01127A1 (en) 2005-11-10
DOP2001000238A (es) 2003-01-31
JP2004507518A (ja) 2004-03-11
HN2001000216A (es) 2002-05-22
HUP0300828A2 (hu) 2003-09-29
CN1458921A (zh) 2003-11-26
NO20030844L (no) 2003-02-25
EA200300187A1 (ru) 2003-08-28
BR0113520A (pt) 2003-06-24
MXPA03001654A (es) 2004-09-10
SK2072003A3 (en) 2004-01-08
WO2002018319A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
SV2002000601A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
HN1999000072A (es) Preparaciones farmaceuticas estabilizadas de gaba pentina y proceso para prepararla.
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
BR0112584A (pt) ésteres oxigenados de ácidos benzidroxâmicos de 4-iodofenilamino
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
HN1999000045A (es) Derivados biciclicos del acido hidroxamico
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
HN2002000198A (es) Composiciones farmaceuticas de amlodipina y atorvastatina
BR0311242A (pt) Processo para preparar modafinil
ES2166051T3 (es) Productos intermedios y procedimiento para preparar olanzapina.
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
DE60129032D1 (de) Creatinester-pronutrient-verbindungen und formulierungen
AR028078A1 (es) Proceso para la produccion de grrnulos de enzimas
DK1250329T3 (da) Phenothiaziner på prillform
PT1252327E (pt) Processo para a separacao enzimatica de racematos de derivados de aminometilaril-ciclo-hexanol
IT1317073B1 (it) Esteri dell'acido fenilbutirrico, procedimenti per la loro produzionee loro impiego terapeutico.
PT1339703E (pt) Processo para a preparacao de paclitaxel
CR6904A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
AR027751A1 (es) Proceso para la n-formilacion selectiva de n-hidroxilaminas
BR0113727A (pt) Processo para a produção de halo-4-fenoxiquinolinas
AR028111A1 (es) Procedimiento para la produccion de isocianatos
HN2000000089A (es) Polimorfos de un diclohidrato cristalino de azobiciclo (2,2,2) oct - 3 - ilamina y sus composiciones farmaceuticas.

Legal Events

Date Code Title Description
FD Lapse
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载